{"transactions":[{"id":765199,"issuer":{"id":6962,"kind":"organization","name":"Telomir Pharmaceuticals, Inc."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Non-Qualified Stock Options (right to buy)","published_at":"2026-05-23T00:00:22.000Z","date":"2026-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2000000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person agreed to cancellation of options granted to him on 08/27/2024 and 05/27/2025, in exchange for new options having a lower exercise price."}],"balance_after":0,"derivative":{"exercise_price":2.1,"exercise_date":"2025-05-27","expiration_date":"2035-05-27","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001493152-26-025116","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1971532/000149315226025116/ownership.xml","form_type":"4"}},{"id":765198,"issuer":{"id":6962,"kind":"organization","name":"Telomir Pharmaceuticals, Inc."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Non-Qualified Stock Options (right to buy)","published_at":"2026-05-23T00:00:22.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":2000000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person agreed to cancellation of options granted to him on 08/27/2024 and 05/27/2025, in exchange for new options having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options are fully exercisable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person agreed to cancellation of options granted to him on 08/27/2024 and 05/27/2025, in exchange for new options having a lower exercise price."}],"balance_after":2000000,"derivative":{"exercise_price":1.3,"expiration_date":"2036-05-21","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001493152-26-025116","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1971532/000149315226025116/ownership.xml","form_type":"4"}},{"id":765197,"issuer":{"id":6962,"kind":"organization","name":"Telomir Pharmaceuticals, Inc."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Incentive Stock Options (right to buy)","published_at":"2026-05-23T00:00:22.000Z","date":"2026-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1960170,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person agreed to cancellation of options granted to him on 08/27/2024 and 05/27/2025, in exchange for new options having a lower exercise price."}],"balance_after":0,"derivative":{"exercise_price":5.02,"exercise_date":"2024-08-27","expiration_date":"2034-08-27","underlying":"Common Stock","underlying_shares":1960170},"source":{"system":"sec-edgar","filing":"0001493152-26-025116","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1971532/000149315226025116/ownership.xml","form_type":"4"}},{"id":765196,"issuer":{"id":6962,"kind":"organization","name":"Telomir Pharmaceuticals, Inc."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Incentive Stock Options (right to buy)","published_at":"2026-05-23T00:00:22.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":1960170,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person agreed to cancellation of options granted to him on 08/27/2024 and 05/27/2025, in exchange for new options having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options are fully exercisable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person agreed to cancellation of options granted to him on 08/27/2024 and 05/27/2025, in exchange for new options having a lower exercise price."}],"balance_after":1960170,"derivative":{"exercise_price":1.3,"expiration_date":"2036-05-21","underlying":"Common Stock","underlying_shares":1960170},"source":{"system":"sec-edgar","filing":"0001493152-26-025116","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1971532/000149315226025116/ownership.xml","form_type":"4"}},{"id":800663,"issuer":{"id":6962,"kind":"organization","name":"Telomir Pharmaceuticals, Inc."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2026-04-24T20:05:23.000Z","date":"2026-04-22","kind":"other","planned":false,"acquired":true,"shares":7319710,"price":1.37,"value":10028002.7,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of common stock, no par value of the Issuer issued to the Reporting Person are in exchange for the Reporting Person's shares of TELI Pharmaceuticals, Inc. (\"TELI\") in connection with the Issuer's acquisition of TELI."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock, no par value of the Issuer issued to the Reporting Person are in exchange for the Reporting Person's shares of TELI Pharmaceuticals, Inc. (\"TELI\") in connection with the Issuer's acquisition of TELI."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock, no par value of the Issuer issued to the Reporting Person are in exchange for the Reporting Person's shares of TELI Pharmaceuticals, Inc. (\"TELI\") in connection with the Issuer's acquisition of TELI."}],"balance_after":7319710,"source":{"system":"sec-edgar","filing":"0001493152-26-018911","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971532/000149315226018911/ownership.xml","form_type":"4"}},{"id":822359,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-04-01T21:00:00.000Z","date":"2026-03-30","kind":"grant","planned":false,"acquired":true,"shares":83500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs were issued to the Reporting Person on the Grant Date, pursuant to the Plan. All of the RSU shall vested on the Grant Date."}],"balance_after":83500,"derivative":{"expiration_date":"2036-03-30","underlying":"Common Stock","underlying_shares":83500},"source":{"system":"sec-edgar","filing":"0001493152-26-014697","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315226014697/ownership.xml","form_type":"4"}},{"id":900243,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Options (right to buy)","published_at":"2026-02-18T01:30:02.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":3155170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the grant of Issuer's common stock, par value $0.0001 (\"Common Stock\") that should have been reported on Form 4."},{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents grants of options with underlying shares of Common Stock under the Plan, for awards granted in accordance with the Issuer's CEO's Long-Term Incentive Plan. The options hereunder vested upon issuance."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents grants of options with underlying shares of Common Stock under the Plan, for awards granted in accordance with the Issuer's CEO's Long-Term Incentive Plan. The options hereunder vested upon issuance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Represents grants of options with underlying shares of Common Stock under the Plan, for awards granted in accordance with the Issuer's CEO's Long-Term Incentive Plan. The options hereunder vested upon issuance."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Represents grants of options with underlying shares of Common Stock under the Plan, for awards granted in accordance with the Issuer's CEO's Long-Term Incentive Plan. The options hereunder vested upon issuance."}],"balance_after":3155170,"derivative":{"exercise_price":1.45,"expiration_date":"2035-12-17","underlying":"Common Stock","underlying_shares":3155170},"source":{"system":"sec-edgar","filing":"0001493152-26-007226","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315226007226/ownership.xml","form_type":"5"}},{"id":900242,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Options (right to buy)","published_at":"2026-02-18T01:30:02.000Z","date":"2025-10-16","kind":"exercise","planned":false,"acquired":true,"shares":379000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Represents exercise of 379,000 stock options to purchase Common Stock under the Plan that were issued to the Reporting Person on May 28, 2024 that were vested in full and became exercisable on the same date, pursuant to a grant under the Plan at an exercise price of $0.84 each."}],"balance_after":379000,"derivative":{"exercise_price":0.84,"exercise_date":"2025-10-16","expiration_date":"2034-05-28","underlying":"Common Stock","underlying_shares":379000},"source":{"system":"sec-edgar","filing":"0001493152-26-007226","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315226007226/ownership.xml","form_type":"5"}},{"id":900241,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Options (right to buy)","published_at":"2026-02-18T01:30:02.000Z","date":"2025-10-16","kind":"exercise","planned":false,"acquired":true,"shares":234595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents exercise of 234,595 stock options to purchase Common Stock under the Plan that were issued to the Reporting Person on March 26, 2024, with 50% of such options vesting on the six-month anniversary date of the grant, and the remaining half vesting on the one-year anniversary date of the grant, pursuant to a grant under the Plan at an exercise price of $1.16 each."}],"balance_after":234595,"derivative":{"exercise_price":1.16,"exercise_date":"2025-10-16","expiration_date":"2034-03-26","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001493152-26-007226","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315226007226/ownership.xml","form_type":"5"}},{"id":900240,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2026-02-18T01:30:02.000Z","date":"2025-10-16","kind":"sale","planned":false,"acquired":false,"shares":613595,"price":2.11,"value":1294685.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the grant of Issuer's common stock, par value $0.0001 (\"Common Stock\") that should have been reported on Form 4."}],"balance_after":3592666,"source":{"system":"sec-edgar","filing":"0001493152-26-007226","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315226007226/ownership.xml","form_type":"5"}},{"id":900239,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2026-02-18T01:30:02.000Z","date":"2025-10-16","kind":"exercise","planned":false,"acquired":true,"shares":379000,"price":0.84,"value":318360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the grant of Issuer's common stock, par value $0.0001 (\"Common Stock\") that should have been reported on Form 4."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents exercise of 379,000 stock options to purchase Common Stock under the Plan that were issued to the Reporting Person on May 28, 2024 that were vested in full and became exercisable on the same date, pursuant to a grant under the Plan at an exercise price of $0.84 each."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents exercise of 379,000 stock options to purchase Common Stock under the Plan that were issued to the Reporting Person on May 28, 2024 that were vested in full and became exercisable on the same date, pursuant to a grant under the Plan at an exercise price of $0.84 each."}],"balance_after":4206259,"source":{"system":"sec-edgar","filing":"0001493152-26-007226","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315226007226/ownership.xml","form_type":"5"}},{"id":900238,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2026-02-18T01:30:02.000Z","date":"2025-10-16","kind":"exercise","planned":false,"acquired":true,"shares":234595,"price":1.16,"value":272130.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the grant of Issuer's common stock, par value $0.0001 (\"Common Stock\") that should have been reported on Form 4."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents exercise of 234,595 stock options to purchase Common Stock under the Plan that were issued to the Reporting Person on March 26, 2024, with 50% of such options vesting on the six-month anniversary date of the grant, and the remaining half vesting on the one-year anniversary date of the grant, pursuant to a grant under the Plan at an exercise price of $1.16 each."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents exercise of 234,595 stock options to purchase Common Stock under the Plan that were issued to the Reporting Person on March 26, 2024, with 50% of such options vesting on the six-month anniversary date of the grant, and the remaining half vesting on the one-year anniversary date of the grant, pursuant to a grant under the Plan at an exercise price of $1.16 each."}],"balance_after":3827259,"source":{"system":"sec-edgar","filing":"0001493152-26-007226","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315226007226/ownership.xml","form_type":"5"}},{"id":900237,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2026-02-18T01:30:02.000Z","date":"2025-03-26","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":1.45,"value":90625.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the grant of Issuer's common stock, par value $0.0001 (\"Common Stock\") that should have been reported on Form 4."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents grants of RSUs with underlying shares of Common Stock under the Issuer's 2024 Omnibus Equity Incentive Plan (the \"Plan\"), for awards granted in accordance with the Issuer's CEO's Long-Term Incentive Plan. The RSUs hereunder vested upon issuance."}],"balance_after":3592666,"source":{"system":"sec-edgar","filing":"0001493152-26-007226","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315226007226/ownership.xml","form_type":"5"}},{"id":900236,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2026-02-18T01:30:02.000Z","date":"2025-03-26","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":1.45,"value":90625.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the grant of Issuer's common stock, par value $0.0001 (\"Common Stock\") that should have been reported on Form 4."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents grants of RSUs with underlying shares of Common Stock under the Issuer's 2024 Omnibus Equity Incentive Plan (the \"Plan\"), for awards granted in accordance with the Issuer's CEO's Long-Term Incentive Plan. The RSUs hereunder vested upon issuance."}],"balance_after":3530166,"source":{"system":"sec-edgar","filing":"0001493152-26-007226","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315226007226/ownership.xml","form_type":"5"}},{"id":1023894,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-04T00:00:16.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":2685456,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents 2,685,456 restricted shares of common stock, par value $0.0001 of the Issuer issued as compensation for the Issuer's acquisition of SKNY Pharmaceuticals, Inc."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents 2,685,456 restricted shares of common stock, par value $0.0001 of the Issuer issued as compensation for the Issuer's acquisition of SKNY Pharmaceuticals, Inc."}],"balance_after":3530156,"source":{"system":"sec-edgar","filing":"0001493152-25-016957","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315225016957/ownership.xml","form_type":"4"}},{"id":1035962,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (right to buy)","published_at":"2025-09-19T00:00:04.000Z","date":"2025-09-18","kind":"grant","planned":true,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on September 15, 2025."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The board of directors of the Company approved to reprice the options from its previous exercise price of $6.50 to $1.38. All of the other terms of the option remain unchanged."},{"field":"shares","element":"transactionShares","label":"F5","text":"The options were previously issued to the Reporting Person on August 17, 2023, and are now fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The board of directors of the Company approved to reprice the options from its previous exercise price of $5.00 to $1.38. All of the other terms of the option remain unchanged."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"The options were previously issued to the Reporting Person on August 17, 2023, and are now fully vested."}],"balance_after":150000,"derivative":{"exercise_price":1.38,"expiration_date":"2033-08-17","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-25-014114","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315225014114/ownership.xml","form_type":"4"}},{"id":1035961,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (right to buy)","published_at":"2025-09-19T00:00:04.000Z","date":"2025-09-18","kind":"grant","planned":true,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on September 15, 2025."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The board of directors of the Company approved to reprice the options from its previous exercise price of $5.00 to $1.38. All of the other terms of the option remain unchanged."},{"field":"shares","element":"transactionShares","label":"F3","text":"The options were previously issued to the Reporting Person on April 28, 2023, and are now fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The board of directors of the Company approved to reprice the options from its previous exercise price of $5.00 to $1.38. All of the other terms of the option remain unchanged."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The options were previously issued to the Reporting Person on April 28, 2023, and are now fully vested."}],"balance_after":150000,"derivative":{"exercise_price":1.38,"expiration_date":"2033-04-28","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-25-014114","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315225014114/ownership.xml","form_type":"4"}},{"id":1048997,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-03T20:05:25.000Z","date":"2025-08-29","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":1.37,"value":85625.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents 62,500 RSUs vesting immediately, granted and issued to the Reporting Person from the Issuer's 2022 Omnibus Incentive Plan in connection with the Reporting Person's achievement of certain milestones pursuant to the Reporting Person's Executive Incentive Compensation Plan."}],"balance_after":844700,"source":{"system":"sec-edgar","filing":"0001641172-25-026388","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000164117225026388/ownership.xml","form_type":"4"}},{"id":1128802,"issuer":{"id":6962,"kind":"organization","name":"Telomir Pharmaceuticals, Inc."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2025-05-31T00:00:11.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs were issued to the Reporting Person on May 28, 2025, pursuant to a grant under the Plan. The RSUs are fully vested as of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each restricted stock unit represents a right to receive one share of Issuer's common stock."}],"balance_after":400000,"derivative":{"underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001641172-25-013148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1971532/000164117225013148/ownership.xml","form_type":"4"}},{"id":1128801,"issuer":{"id":6962,"kind":"organization","name":"Telomir Pharmaceuticals, Inc."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Non-Qualified Options","published_at":"2025-05-31T00:00:11.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on May 27, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were issued to the Reporting Person on May 28, 2025, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the \"Plan\"). The stock options are fully vested as of the date of grant."}],"balance_after":2000000,"derivative":{"exercise_price":2.1,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001641172-25-013148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971532/000164117225013148/ownership.xml","form_type":"4"}},{"id":1283358,"issuer":{"id":6962,"kind":"organization","name":"Telomir Pharmaceuticals, Inc."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2025-02-04T21:05:32.000Z","date":"2024-08-19","kind":"sale","planned":false,"acquired":false,"shares":200,"price":6.2,"value":1240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the sale of common stock that should have been reported on Form 4."}],"balance_after":29600,"source":{"system":"sec-edgar","filing":"0001493152-25-004853","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1971532/000149315225004853/ownership.xml","form_type":"5"}},{"id":1283357,"issuer":{"id":6962,"kind":"organization","name":"Telomir Pharmaceuticals, Inc."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2025-02-04T21:05:32.000Z","date":"2024-08-19","kind":"sale","planned":false,"acquired":false,"shares":200,"price":6.01,"value":1202.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the sale of common stock that should have been reported on Form 4."}],"balance_after":29600,"source":{"system":"sec-edgar","filing":"0001493152-25-004853","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971532/000149315225004853/ownership.xml","form_type":"5"}},{"id":1336677,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-12-10T22:15:35.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs were issued to the Reporting Person on the Grant Date, pursuant to the Plan. Half of the shares subject to the RSU shall vest on the Grant Date and the remaining half of the shares subject to the RSU shall vest six months after the Grant Date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Represents 500,000 RSUs that were issued to the Reporting Person on December 6, 2024 under the Plan. Half of the shares subject to the RSU shall vest on the Grant Date and the remaining half of the shares subject to the RSU shall vest six months after the Grant Date."}],"balance_after":500000,"derivative":{"expiration_date":"2034-12-09","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001493152-24-049503","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315224049503/ownership.xml","form_type":"4"}},{"id":1336676,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (right to buy)","published_at":"2024-12-10T22:15:35.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on December 6, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were issued to the Reporting Person on December 6, 2024 (the \"Grant Date\"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the \"Plan\"). Half of the shares subject to the option shall vest on the Grant Date and the remaining half of the shares subject to the option shall vest six months after the Grant Date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents 2,000,000 stock options that were issued to the Reporting Person on December 6, 2024 under the Plan. Half of the shares subject to the option shall vest on the Grant Date and the remaining half of the shares subject to the option shall vest six months after the Grant Date."}],"balance_after":2000000,"derivative":{"exercise_price":1.19,"expiration_date":"2034-12-09","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001493152-24-049503","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315224049503/ownership.xml","form_type":"4"}},{"id":1348757,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-11-27T21:15:24.000Z","date":"2024-11-20","kind":"sale","planned":true,"acquired":false,"shares":44590,"price":1.27,"value":56629.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were affected pursuant to a Rule 10b51 Trading Plan adopted by the Reporting Person on 8/20/2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions."}],"balance_after":1061200,"source":{"system":"sec-edgar","filing":"0001493152-24-047998","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315224047998/ownership.xml","form_type":"4"}},{"id":1348756,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-11-27T21:15:24.000Z","date":"2024-11-19","kind":"sale","planned":true,"acquired":false,"shares":55410,"price":1.39,"value":77019.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were affected pursuant to a Rule 10b51 Trading Plan adopted by the Reporting Person on 8/20/2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions."}],"balance_after":1105790,"source":{"system":"sec-edgar","filing":"0001493152-24-047998","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315224047998/ownership.xml","form_type":"4"}},{"id":1419602,"issuer":{"id":6962,"kind":"organization","name":"Telomir Pharmaceuticals, Inc."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & Chairman"}}],"security":"Incentive Stock Options (right to buy)","published_at":"2024-08-29T20:05:14.000Z","date":"2024-08-27","kind":"grant","planned":false,"acquired":true,"shares":1960170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on August 26, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were issued to the Reporting Person on August 26, 2024, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the \"Plan\"). Fifty percent of the stock options vested immediately upon issuance and the remaining fifty percent of the stock options are to vest on February 26, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The stock options were issued to the Reporting Person on August 26, 2024, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the \"Plan\"). Fifty percent of the stock options vested immediately upon issuance and the remaining fifty percent of the stock options are to vest on February 26, 2025."}],"balance_after":1960170,"derivative":{"exercise_price":5.02,"expiration_date":"2034-08-27","underlying":"Common Stock","underlying_shares":1960170},"source":{"system":"sec-edgar","filing":"0001493152-24-034370","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971532/000149315224034370/ownership.xml","form_type":"4"}},{"id":1497386,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Incentive Stock Options (right to buy)","published_at":"2024-05-30T22:00:06.000Z","date":"2024-05-28","kind":"grant","planned":false,"acquired":true,"shares":379000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on May 28, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were issued to the Reporting Person on May 28, 2024, pursuant to a grant under the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the \"Plan\"). The stock options vested in full and became exercisable immediately upon issuance on the grant date, May 28, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents 50,000 stock options that were issued to the Reporting Person on April 28, 2023 that were vested in full and became exercisable on the same date, pursuant to a grant under the Issuer's Plan at an exercise price of $5.00 each, (ii) 150,000 stock options that were issued to the Reporting Person on August 17, 2023, pursuant to a grant under the Issuer's Plan which vested in full on August 17, 2023 at an exercise price of $6.50 each, (iii) 50,000 stock options that were issued to the Reporting Person on August 17, 2023 that vested in full and became exercisable on April 28, 2024, pursuant to a grant under the Issuer's Plan at an exercise price of $6.50 each, and (iv) 379,000 stock options that were issued to the Reporting Person on May 28, 2024 that were vested in full and became exercisable on the same date, pursuant to a grant under the Issuer's Plan at an exercise price of $0.84 each."}],"balance_after":629000,"derivative":{"exercise_price":0.84,"expiration_date":"2034-05-28","underlying":"Common Stock","underlying_shares":379000},"source":{"system":"sec-edgar","filing":"0001493152-24-022029","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315224022029/ownership.xml","form_type":"4"}},{"id":1504879,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-05-22T21:42:53.000Z","date":"2024-05-21","kind":"purchase","planned":false,"acquired":true,"shares":800,"price":0.97,"value":776.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are directly owned by Mr. Aminov."}],"balance_after":382200,"source":{"system":"sec-edgar","filing":"0001493152-24-021069","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315224021069/ownership.xml","form_type":"4"}},{"id":1504878,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-05-22T21:42:53.000Z","date":"2024-05-21","kind":"purchase","planned":false,"acquired":true,"shares":800,"price":1.01,"value":808.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are directly owned by Mr. Aminov."}],"balance_after":381400,"source":{"system":"sec-edgar","filing":"0001493152-24-021069","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315224021069/ownership.xml","form_type":"4"}},{"id":1504877,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-05-22T21:42:53.000Z","date":"2024-05-21","kind":"purchase","planned":false,"acquired":true,"shares":600,"price":0.87,"value":522.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are directly owned by Mr. Aminov."}],"balance_after":380600,"source":{"system":"sec-edgar","filing":"0001493152-24-021069","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315224021069/ownership.xml","form_type":"4"}},{"id":1504876,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-05-22T21:42:53.000Z","date":"2024-05-21","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":0.85,"value":850.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are directly owned by Mr. Aminov."}],"balance_after":380000,"source":{"system":"sec-edgar","filing":"0001493152-24-021069","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315224021069/ownership.xml","form_type":"4"}},{"id":1504875,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-05-22T21:42:53.000Z","date":"2024-05-21","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":0.84,"value":1680.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are directly owned by Mr. Aminov."}],"balance_after":379000,"source":{"system":"sec-edgar","filing":"0001493152-24-021069","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315224021069/ownership.xml","form_type":"4"}},{"id":1504874,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-05-22T21:42:53.000Z","date":"2024-05-21","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":1.02,"value":510.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are directly owned by Mr. Aminov."}],"balance_after":377000,"source":{"system":"sec-edgar","filing":"0001493152-24-021069","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315224021069/ownership.xml","form_type":"4"}},{"id":1504873,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-05-22T21:42:53.000Z","date":"2024-05-21","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":1.03,"value":1030.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are directly owned by Mr. Aminov."}],"balance_after":376500,"source":{"system":"sec-edgar","filing":"0001493152-24-021069","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315224021069/ownership.xml","form_type":"4"}},{"id":1504872,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-05-22T21:42:53.000Z","date":"2024-05-21","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":1,"value":2000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are directly owned by Mr. Aminov."}],"balance_after":375500,"source":{"system":"sec-edgar","filing":"0001493152-24-021069","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315224021069/ownership.xml","form_type":"4"}},{"id":1559125,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2024-03-27T21:53:49.000Z","date":"2024-03-26","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on March 26, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were granted under the Issuer's 2022 Amended and Restated Omnibus Incentive Plan (the \"Plan\") whereby 50% of such incentive options, or 150,000 options, will vest on the six month anniversary of the of the grant, or September 26, 2024, and the remaining 50% will vest on the first anniversary of the grant date, March 26, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents 50,000 stock options that were issued to the Reporting Person on April 28, 2023 that were vested in full and became exercisable on the same date, pursuant to a grant under the Issuer's Plan at an exercise price of $5.00 each, (ii) 150,000 stock options were issued to the Reporting Person on August 17, 2023, pursuant to a grant under the Issuer's Plan which vested in full on August 17,2023 at an exercise price of $6.50 each and (iii) 50,000 stock options were issued to the Reporting Person on August 17, 2023, pursuant to a grant under the Issuer's Plan which will vest in full on April 28. 2024 at an exercise price of $6.50 each."}],"balance_after":250000,"derivative":{"exercise_price":1.15,"expiration_date":"2034-03-26","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001493152-24-011573","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315224011573/ownership.xml","form_type":"4"}},{"id":1800358,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":44568,"kind":"person","name":"Aminov Erez","position":1,"cik":"0001986112","reported_name":"Aminov Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Stock Options","published_at":"2023-08-21T22:00:13.000Z","date":"2023-08-17","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on August 17, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were issued to the Reporting Person on August 17,2023, pursuant to a grant under the Issuer's 2022 Omnibus Incentive Plan, as amended and restated. The award vests in full on August 17,2023."}],"balance_after":150000,"derivative":{"exercise_price":6.5,"expiration_date":"2033-08-17","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-23-029732","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315223029732/ownership.xml","form_type":"4"}}]}